Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| natural killer cell | 3 studies | 16% ± 1% | |
| epithelial cell | 3 studies | 22% ± 6% |
Insufficient scRNA-seq data for expression of CTDP1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 1808.05 | 1445 / 1445 | 100% | 18.47 | 183 / 183 |
| ovary | 100% | 981.32 | 180 / 180 | 100% | 14.00 | 430 / 430 |
| prostate | 100% | 1942.35 | 245 / 245 | 100% | 18.10 | 502 / 502 |
| uterus | 100% | 1659.88 | 170 / 170 | 100% | 20.30 | 459 / 459 |
| breast | 100% | 1790.01 | 459 / 459 | 100% | 18.36 | 1117 / 1118 |
| thymus | 100% | 1801.56 | 652 / 653 | 100% | 19.29 | 605 / 605 |
| intestine | 100% | 1957.10 | 966 / 966 | 100% | 19.60 | 526 / 527 |
| lung | 100% | 1974.80 | 577 / 578 | 100% | 17.10 | 1154 / 1155 |
| stomach | 100% | 1509.84 | 359 / 359 | 100% | 18.40 | 285 / 286 |
| skin | 100% | 2955.24 | 1809 / 1809 | 100% | 23.95 | 470 / 472 |
| adrenal gland | 100% | 1413.54 | 258 / 258 | 100% | 12.91 | 229 / 230 |
| kidney | 100% | 1549.00 | 89 / 89 | 100% | 14.19 | 897 / 901 |
| bladder | 100% | 1878.86 | 21 / 21 | 99% | 19.04 | 501 / 504 |
| pancreas | 99% | 1021.55 | 326 / 328 | 100% | 16.11 | 178 / 178 |
| liver | 100% | 1199.19 | 226 / 226 | 99% | 11.83 | 403 / 406 |
| brain | 98% | 924.49 | 2582 / 2642 | 100% | 16.06 | 704 / 705 |
| adipose | 100% | 1667.53 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 25.11 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 37.98 | 29 / 29 |
| spleen | 100% | 2800.12 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 22.64 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 15.68 | 1 / 1 |
| blood vessel | 100% | 1682.84 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| peripheral blood | 99% | 3494.86 | 924 / 929 | 0% | 0 | 0 / 0 |
| muscle | 99% | 1221.11 | 797 / 803 | 0% | 0 | 0 / 0 |
| heart | 98% | 841.70 | 843 / 861 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006470 | Biological process | protein dephosphorylation |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0006368 | Biological process | transcription elongation by RNA polymerase II |
| GO_0051301 | Biological process | cell division |
| GO_0061052 | Biological process | negative regulation of cell growth involved in cardiac muscle cell development |
| GO_0010458 | Biological process | exit from mitosis |
| GO_0043923 | Biological process | positive regulation by host of viral transcription |
| GO_0030496 | Cellular component | midbody |
| GO_0000922 | Cellular component | spindle pole |
| GO_0005813 | Cellular component | centrosome |
| GO_0032991 | Cellular component | protein-containing complex |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0051233 | Cellular component | spindle midzone |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
| GO_0005819 | Cellular component | spindle |
| GO_0005634 | Cellular component | nucleus |
| GO_0004721 | Molecular function | phosphoprotein phosphatase activity |
| GO_0017018 | Molecular function | myosin phosphatase activity |
| GO_0001096 | Molecular function | TFIIF-class transcription factor complex binding |
| GO_0030957 | Molecular function | Tat protein binding |
| GO_0008420 | Molecular function | RNA polymerase II CTD heptapeptide repeat phosphatase activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | CTDP1 |
| Protein name | RNA polymerase II subunit A C-terminal domain phosphatase (EC 3.1.3.16) (TFIIF-associating CTD phosphatase) protein-serine/threonine phosphatase (EC 3.1.3.16) RNA polymerase II subunit A C-terminal domain phosphatase (EC 3.1.3.16) |
| Synonyms | FCP1 |
| Description | FUNCTION: Processively dephosphorylates 'Ser-2' and 'Ser-5' of the heptad repeats YSPTSPS in the C-terminal domain of the largest RNA polymerase II subunit. This promotes the activity of RNA polymerase II. Plays a role in the exit from mitosis by dephosphorylating crucial mitotic substrates (USP44, CDC20 and WEE1) that are required for M-phase-promoting factor (MPF)/CDK1 inactivation. . FUNCTION: This promotes the activity of RNA polymerase II. . FUNCTION: This promotes the activity of RNA polymerase II. . FUNCTION: This promotes the activity of RNA polymerase II. . |
| Accessions | A0A0J9YWB6 ENST00000632905.1 A0A0J9YWJ4 K7EPW4 ENST00000632932.1 ENST00000632450.1 A0A0A0MR03 ENST00000632301.1 ENST00000590635.5 ENST00000613122.5 [Q9Y5B0-1] ENST00000299543.9 K7EJD2 ENST00000075430.11 [Q9Y5B0-4] ENST00000591598.5 Q9Y5B0 |